The Valley Desk

NCT04611880 · Interventional trial

Crizanlizumab for Treatment of Retinal Vasculopathy With Cerebral Leukoencephalopathy (RVCL)

Overall registry status Completed

Phase 2

Conditions RVCL - Retinal Vasculopathy Cerebral Leukoencephalopathy

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov